SCHEMBL7235148

SCHEMBL7235148

N[C@H](CC(=O)O)c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.46
GRIK1 P39086 1/20 0.44
GRIK2 Q13002 1/20 0.44
MMP12 P39900 1/20 0.44
EPHX2 P34913 1/20 0.44
ALDH1A1 P00352 1/20 0.43
KMT2A Q03164 2/20 0.43
ITGB3 P05106 1/20 0.43
ITGAV P06756 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PTPN1 P18031 1/20 0.42
SUCNR1 Q9BXA5 1/20 0.42
HPGD P15428 1/20 0.40
SCN10A Q9Y5Y9 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
SLC7A5 Q01650 2/20 0.40
MRGPRX4 Q96LA9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5371011 1.00 EPHX1 (0.46) EPHX1GRIK1GRIK2MMP12EPHX2
SCHEMBL28114756 0.87 EPHX1 (0.46) EPHX1GRIK1GRIK2MMP12EPHX2
Hydrochloric Acid SCHEMBL16563786 0.86 EPHX1 (0.45) EPHX1GRIK1GRIK2MMP12EPHX2
SCHEMBL27582399 0.84 KMT2A (0.43) ALDH1A1KMT2ASMN1; SMN2
SCHEMBL29178245 0.83 FNTA (0.47) EPHX1MMP12EPHX2ALDH1A1KMT2A
SCHEMBL7169484 0.83 ALDH1A1 (0.46) EPHX1EPHX2ALDH1A1KMT2ASMN1; SMN2
SCHEMBL20545894 0.82 CTSA (0.52) EPHX1MMP12KMT2ASMN1; SMN2SUCNR1
SCHEMBL20545896 0.82 CTSA (0.52) EPHX1MMP12KMT2ASMN1; SMN2SUCNR1
SCHEMBL20764626 0.82 KMT2A (0.61) EPHX1MMP12KMT2ASMN1; SMN2
SCHEMBL30412148 0.82 KMT2A (0.61) EPHX1MMP12KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645939-B1 Very late antigen-4 (VLA) integrin antagonists; antiallergens, antiasthmatics, and antiinflammatory agents; multiple sclerosis, autoimmune disease treatment MERCK & CO., INC. 2003-11-11 US disclosed